American Thoracic Society, Infectious Disease Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care, 2005; 171(4):388–416.
2.
LeJ, AshleyED, NeuhauserMM, BrownJ, GentryC, KlepserME, MarrAM, et al; Society of Infectious Diseases Pharmacists Aerosolized Antimicrobials Task Force. Consensus summary of aerosolized antimicrobial agents: application of guideline criteria. Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2010; 30(6):562–584.
3.
ImbertiR, CusatoM, VillaniP, CarnevaleL, IottiGA, LangerM, RegazziM. Steady-state pharmacokinetics and BAL concentration of colistin in critically Ill patients after IV colistin methane sulfonate administration. Chest, 2010; 138(6):1333–1339.
4.
PanidisD, MarkantonisSL, BoutzoukaE, KaratzasS, BaltopoulosG. Penetration of gentamicin into the alveolar lining fluid of critically ill patients with ventilator-associated pneumonia. Chest, 2005; 128(2):545–552.
5.
RhombergPR, FritscheTR, SaderHS, JonesRN. Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA). Diagn Microbiol Infect Dis, 2006; 56(1):57–62.
6.
LuytCE, ClavelM, GuntupalliK, JohannigmanJ, KennedyJI, WoodC, et al. Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia. Crit Care, 2009; 13(6):R200.
7.
IoannidouE, SiemposII, FalagasME. Administration of antimicrobials via the respiratory tract of patients with nosocomial pneumonia: a meta-analysis. J Antimicrob Chemother, 2007; 60(6):1216–1226.
8.
FlorescuDF, QiuF, McCartanMA, MindruC, FeyPD, KalilAC. What is the efficacy and safety of colistin for the treatment of ventilator-associated pneumonia? A systematic review and meta-analysis. Clin Infect Dis, 2012; 54(5):670–680.
9.
MohrAM, SifriZC, HorngHS, SadekR, SavetamalA, HauserCJ, LivingstonDH. Use of aerosolized aminoglycosides in the treatment of Gram-negative ventilator-associated pneumonia. Surg Infect, 2007; 8(3):349–357.
10.
CzosnowskiQA, WoodGC, MagnottiLJ, CroceMA, SwansonJM, BoucherBA, FabianTC. Adjunctive aerosolized antibiotics for the treatment of ventilator-associated pneumonia. Pharmacother, 2009; 29(9):1051–1060.
11.
MichalopoulosA, FotakisD, VirtziliS, VletsasC, RaftopoulouS, MastoraZ, FalagasME. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multi-drug resistant Gram-negative bacteria: a prospective study. Respir Med, 2008; 102(3):407–412.
12.
KofteridisDP, AlexopoulouC, ValachisA, MarakiS, DimopoulouD, GeorgopoulosD, SamonisG. Aerosolized plus intravenous colistin versus intravenous colisitn alone for the treatment of ventilator-associated pneumonia: a matched case-control study. Clin Infect Dis, 2010; 51(11):1238–1244.
13.
MichalopoulosA, KasiakouSK, MastoraZ, RellosK, KapaskelisAM, FalagasME. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug resistant Gram-negative bacteria in patients without cystic fibrosis. Crit Care, 2005; 9(1):R53–59.
14.
ArnoldHM, SawyerAM, KollefMH. Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia. Respir Care, 2012; 57(8):1226–1233.
15.
WoodGC, SwansonJM. Aerosolised antibacterials for the prevention and treatment of hospital-acquired pneumonia. Drugs, 2007; 67(6):903–914.
